# Cardiovascular Effects of Angiotensin-(1-7) in Obesity Hypertension

> **NCT06482853** · EARLY_PHASE1 · RECRUITING · sponsor: **Milton S. Hershey Medical Center** · enrollment: 52 (estimated)

## Conditions studied

- Obesity
- Hypertension

## Interventions

- **DRUG:** Angiotensin-(1-7)
- **DRUG:** Saline

## Key facts

- **NCT ID:** NCT06482853
- **Lead sponsor:** Milton S. Hershey Medical Center
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-23
- **Primary completion:** 2029-03
- **Final completion:** 2029-03
- **Target enrollment:** 52 (ESTIMATED)
- **Last updated:** 2025-09-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06482853

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06482853, "Cardiovascular Effects of Angiotensin-(1-7) in Obesity Hypertension". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06482853. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*